Technologies | Ckalist - Free Listing For Search Engines

Targets for future drugs of AD

The hope for future drugs Currently, there are five FDA-approved Alzheimer’s drugs that treat the symptoms of Alzheimer’s — temporarily helping memory and thinking problems — with a sixth drug available globally. But these medications do not treat the...

HUP on memory in AD

Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer’s disease. Abstract AIM: To evaluate the efficacy and safety of tablet huperzine-A (Hup) in patients with Alzheimer’s disease. METHODS: Using multicenter, prospective,...

Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer’s Disease

ORIGINAL ARTICLE A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer’s Disease Mary Sano, Ph.D., Christopher Ernesto, M.S., Ronald G. Thomas, Ph.D., Melville R. Klauber, Ph.D., Kimberly Schafer, M.S., Michael Grundman, M.D.,...

Neurotrope – Alzheimer’s trial Phase 2

Neurotrope misses primary endpoint in Alzheimer’s trial by Nick Paul Taylor | May 1, 2017 6:59am A phase 2 trial of Neurotrope’s Alzheimer’s disease candidate has missed its primary endpoint. The study set out to show bryostatin improved performance on a...

U.S. med tech venture investment wanes

U.S. med tech venture investment wanes–even as venture-backed M&A holds strong by Stacy Lawrence | Jan 11, 2016 12:00pm Venture capital investment in the U.S. jumped to $59 billion last year–almost twice what it was a scant 5 years ago, according to...

The Most Active VCs In Medical Devices

The Most Active VCs In Medical Devices and Their Investments In One Infographic NEA, Versant Ventures, and High-Tech Grunderfonds are the three most active investors in medical device startups. Funding to medical device startups is on track to pick back up this...